InventHelp Inventors Develop New Sleep Mask for Travelers (HOF-431)
PITTSBURGH, May 29, 2024 /PRNewswire/ -- "We wanted to create an improved sleep mask that would increase comfort for travelers when sleeping on a plane or train," said one of two inventors, from Houston, Texas, "so we invented the EYE- PAD. Our design may allow the wearer to sleep more soundly and arrive refreshed and relaxed at their destination."
The patent-pending invention provides a new sleep mask for travelers. In doing so, it enables the wearer to rest the forehead against the seat in front of them or on a tray table. As a result, it increases comfort when traveling by plane, train or bus. The invention features a portable design that is easy to use so it is ideal for travelers. Additionally, it is producible in design variations.
The original design was submitted to the Houston sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 22-HOF-431, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
YOUR LEGAL RIGHTS MAY BE AFFECTED
There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...
On July 02, 2024, the BC Government designated Psychotherapy as a Health Profession under the Health Professions Act. The proposal received cabinet approval and was subsequently signed by the Lieutenant Governor. The official order can be viewed...
Whitman-Walker Institute condemns the politically motivated ruling from a federal district court judge that blocks vital nondiscrimination protections for transgender people across the country. Today, a U.S. district court judge in Mississippi issued...
